2015
DOI: 10.1038/ncomms8465
|View full text |Cite
|
Sign up to set email alerts
|

Targeted inhibition of fascin function blocks tumour invasion and metastatic colonization

Abstract: One of the key steps during tumour metastasis is tumour cell migration and invasion, which require actin cytoskeletal reorganization. Among the critical actin cytoskeletal protrusion structures are the filopodia, which act like cell sensory organs to communicate with the extracellular microenvironment and participate in fundamental cell functions such as cell adhesion, spreading and migration in the three-dimensional environment. Fascin is the main actin-bundling protein in filopodia. Using high-throughput scr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
156
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 118 publications
(163 citation statements)
references
References 60 publications
2
156
0
Order By: Relevance
“…Rat IgG1 PE-conjugated Antibody (IC005P), Mouse MARCO PE-conjugated Antibody (FAB2956P), Rat IgG2A PE-conjugated Antibody (IC006P), Mouse Fc gamma RI/CD64 PE-conjugated Antibody (FAB20741P), and Mouse MARCO Antibody (AF2956-SP) were purchased from R&D Systems. Rac1 inhibitor, NSC23766 (1177865-17-6, Cayman Chemical, Ann Arbor, MI, USA); N-WASP inhibitor, Wiskostatin (253449-04-6, Cayman Chemical); Arp2/3 complex inhibitor, CK666 (SML0006, Sigma-Aldrich, St. Louis, MO, USA); Fascin inhibitor (21), C 20 H 14 F 3 N 3 O 2 (L457698-1EA, Sigma-Aldrich). CytoPainter Phalloidin-iFluor 647 Reagent (ab176759) and Anti-Arp2 (phospho T237 + T238) antibody (ab119766) were purchased from abcam (Cambridge, MA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Rat IgG1 PE-conjugated Antibody (IC005P), Mouse MARCO PE-conjugated Antibody (FAB2956P), Rat IgG2A PE-conjugated Antibody (IC006P), Mouse Fc gamma RI/CD64 PE-conjugated Antibody (FAB20741P), and Mouse MARCO Antibody (AF2956-SP) were purchased from R&D Systems. Rac1 inhibitor, NSC23766 (1177865-17-6, Cayman Chemical, Ann Arbor, MI, USA); N-WASP inhibitor, Wiskostatin (253449-04-6, Cayman Chemical); Arp2/3 complex inhibitor, CK666 (SML0006, Sigma-Aldrich, St. Louis, MO, USA); Fascin inhibitor (21), C 20 H 14 F 3 N 3 O 2 (L457698-1EA, Sigma-Aldrich). CytoPainter Phalloidin-iFluor 647 Reagent (ab176759) and Anti-Arp2 (phospho T237 + T238) antibody (ab119766) were purchased from abcam (Cambridge, MA, USA).…”
Section: Methodsmentioning
confidence: 99%
“…Fascin-1 also promoted tumour progression in a mouse genetic model of pancreatic cancer 13. More recently, a small molecule that inhibits actin bundling by fascin-1 was reported to decrease lung metastasis of syngeneic fascin-1–positive breast tumours in mice 18. Therefore, fascin-1 has emerged as a new prospective therapeutic target 19,20…”
Section: Introductionmentioning
confidence: 99%
“…Fascin contains several actin binding sites (15), of which the N-terminal one can be inhibited by phosphorylation of a conserved serine (Ser-39) by means of PKC (16). Due to its up-regulation in many cancers and its association with mortality and metastasis, fascin has emerged as an important biomarker (17,18) and therapeutic target (19,20). However, fascin depletion does not abolish bundling in filopodia (12), and also normal epithelial cells devoid of fascin form filopodia (21) suggesting that other bundling proteins may be involved.…”
mentioning
confidence: 99%